AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Gala Vega
Researcher at Hospital Fundación Jiménez Díaz
Best podcasts with Gala Vega
Ranked by the Snipd community
Aug 9, 2023 • 3min
CDK9 Inhibitors: A Promising Combination Partner in Treating Hematological Malignancies
Researchers discuss the potential of CDK9 inhibitors in treating hematological malignancies by targeting cancer-promoting genes like MYC and MCL1. Preclinical studies show promising results, with enitociclib demonstrating clinical activity in high-grade B lymphoma patients. CDK9 inhibitors may offer synergistic effects when combined with other drugs in the treatment of these malignancies.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode